Abstract
The host immune system recognizes and responds to the selective antigens or epitopes (immunome) of the intruding pathogen over an entire organism. The immune response so generated is ample to confer the desired immunity and protection to the host. This led to the conception of immunome-derived vaccines that exploit selective genome-derived antigens or epitopes from the pathogen’s immunome and not its entire genome or proteome. These are designed to elicit the required immune response and confer protection against future invasions by the same pathogen. Immunoinformatics through its epitope mapping tools allows direct selection of antigens from a pathogen’s genome or proteome, which is critical for the generation of an effective vaccine. This paved way for novel vaccine design strategies based on the mapped epitopes for translational applications that includes prophylactic, therapeutic, and personalized vaccines. In this chapter, various Immunoinformatics tools for epitope mapping are presented along with their applications. The methodology for immunoinformatics-assisted vaccine design is also outlined.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Terry FE, Moise L, Martin RF et al (2015) Time for T? Immunoinformatics addresses vaccine design for neglected tropical and emerging infectious diseases. Expert Rev Vaccines 14:21–35
Poland GA, Whitaker JA, Poland CM et al (2016) Vaccinology in the third millennium: scientific and social challenges. Curr Opin Virol 17:116–125
ServĂn-Blanco R, Zamora-Alvarado R, Gevorkian G et al (2016) Antigenic variability: obstacles on the road to vaccines against traditionally difficult targets. Hum Vaccin Immunother 12:2640–2648
De Groot AS, Martin W (2003) From immunome to vaccine: epitope mapping and vaccine design tools. Novartis Found Symp 254:57–72
Doytchinova IA, Taylor P, Flower DR (2003) Proteomics in vaccinology and immunobiology: an informatics perspective of the immunone. J Biomed Biotechnol 2003:267–290
Jongeneel V (2001) Towards a cancer immunome database. Cancer Immun 1:3
Klade CS (2002) Proteomics approaches towards antigen discovery and vaccine development. Curr Opin Mol Ther 4:216–223
Pederson T (1999) The immunome. Mol Immunol 36:1127–1128
Petrovsky N, Brusic V (2002) Computational immunology: the coming of age. Immunol Cell Biol 80:248–254
Rappuoli R (2001) Reverse vaccinology, a genome-based approach to vaccine development. Vaccine 19:2688–2691
Etz H, Minh DB, Henics T et al (2002) Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus. Proc Natl Acad Sci U S A 99:6573–6578
Weichhart T, Horky M, Söllner J et al (2003) Functional selection of vaccine candidate peptides from Staphylococcus aureus whole-genome expression libraries in vitro. Infect Immun 71:4633–4641
Adamou JE, Heinrichs JH, Erwin AL et al (2001) Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis. Infect Immun 69:949–958
Tettelin H, Masignani V, Cieslewicz MJ et al (2002) Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proc Natl Acad Sci U S A 99:12391–12396
Ross BC, Czajkowski L, Hocking D et al (2001) Identification of vaccine candidate antigens from a genomic analysis of Porphyromonas gingivalis. Vaccine 19:4135–4142
Montigiani S, Falugi F, Scarselli M et al (2002) Genomic approach for analysis of surface proteins in Chlamydia pneumoniae. Infect Immun 70:368–379
Mathiassen S, Lauemøller SL, Ruhwald M et al (2001) Tumor-associated antigens identified by mRNA expression profiling induce protective anti-tumor immunity. Eur J Immunol 31:1239–1246
Robinson WH, Garren H, Utz PJ et al (2002) Millennium award. Proteomics for the development of DNA tolerizing vaccines to treat autoimmune disease. Clin Immunol 103:7–12
De Groot AS (2004) Immunome-derived vaccines. Expert Opin Biol Ther 4:767–772
Ortutay C, Vihinen M (2009) Immunome knowledge base (IKB): an integrated service for immunome research. BMC Immunol 10:3
Chaplin DD (2010) Overview of the immune response. J Allergy Clin Immunol 125:S3–S23
Sarkander J, Hojyo S, Tokoyoda K (2016) Vaccination to gain humoral immune memory. Clin Transl Immunology 5:e120
Altuvia Y, Margalit H (2004) A structure-based approach for prediction of MHC-binding peptides. Methods 34:454–459
Bian H, Hammer J (2004) Discovery of promiscuous HLA-II-restricted T cell epitopes with TEPITOPE. Methods 34:468–475
Brusic V, Bajic VB, Petrovsky N (2004) Computational methods for prediction of T-cell epitopes—a framework for modelling, testing, and applications. Methods 34:436–443
De Groot AS, Bishop EA, Khan B et al (2004) Engineering immunogenic consensus T helper epitopes for a cross-clade HIV vaccine. Methods 34:476–487
Doytchinova IA, Guan P, Flower DR (2004) Quantitative structure-activity relationships and the prediction of MHC supermotifs. Methods 34:444–453
Sung MH, Simon R (2004) Candidate epitope identification using peptide property models: application to cancer immunotherapy. Methods 34:460–467
Singh H, Raghava GP (2001) ProPred: prediction of HLA-DR binding sites. Bioinformatics 17:1236–1237
Zhang GL, Khan AM, Srinivasan KN et al (2005) MULTIPRED: a computational system for prediction of promiscuous HLA binding peptides. Nucleic Acids Res 33:W172–W179
Guan P, Hattotuwagama CK, Doytchinova IA et al (2006) MHCPred 2.0: an updated quantitative T-cell epitope prediction server. Appl Bioinforma 5:55–61
Nielsen M, Lundegaard C, Worning P et al (2003) Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci 12:1007–1017
Larsen MV, Lundegaard C, Lamberth K et al (2007) Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinformatics 8:424
Peters B, Sidney J, Bourne P et al (2005) The immune epitope database and analysis resource: from vision to blueprint. PLoS Biol 3:e91
Lefranc MP, Giudicelli V, Ginestoux C et al (2009) IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res 37:D1006–D1012
Schubert B, Brachvogel HP, Jürges C et al (2015) EpiToolKit—a web-based workbench for vaccine design. Bioinformatics 31:2211–2213
Bhasin M, Raghava GP (2003) Prediction of promiscuous and high-affinity mutated MHC binders. Hybrid Hybridomics 22:229–234
Rammensee H, Bachmann J, Emmerich NP et al (1999) SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50:213–219
Ponomarenko J, Bui HH, Li W et al (2008) ElliPro: a new structure-based tool for the prediction of antibody epitopes. BMC Bioinformatics 9:514
Saha S, Raghava GP (2006) Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins 65:40–48
Saxová P, Buus S, Brunak S et al (2003) Predicting proteasomal cleavage sites: a comparison of available methods. Int Immunol 15:781–787
Odorico M, Pellequer JL (2003) BEPITOPE: predicting the location of continuous epitopes and patterns in proteins. J Mol Recognit 16:20–22
Kringelum JV, Lundegaard C, Lund O et al (2012) Reliable B cell epitope predictions: impacts of method development and improved benchmarking. PLoS Comput Biol 8:e1002829
Jespersen MC, Peters B, Nielsen M et al (2017) BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes. Nucleic Acids Res 45:W24–W29
Mayrose I, Penn O, Erez E et al (2007) Pepitope: epitope mapping from affinity-selected peptides. Bioinformatics 23:3244–3246
El-Manzalawy Y, Dobbs D, Honavar V (2008) Predicting flexible length linear B-cell epitopes. Comput Syst Bioinformatics Conf 7:121–132
van Endert PM, Tampé R, Meyer TH et al (1994) A sequential model for peptide binding and transport by the transporters associated with antigen processing. Immunity 1:491–500
Keşmir C, Nussbaum AK, Schild H et al (2002) Prediction of proteasome cleavage motifs by neural networks. Protein Eng 15:287–296
Nussbaum AK, Kuttler C, Hadeler KP et al (2001) PAProC: a prediction algorithm for proteasomal cleavages available on the WWW. Immunogenetics 53:87–94
Bhasin M, Raghava GP (2004) Analysis and prediction of affinity of TAP binding peptides using cascade SVM. Protein Sci 13:596–607
Dönnes P, Kohlbacher O (2005) Integrated modeling of the major events in the MHC class I antigen processing pathway. Protein Sci 14:2132–2140
Zhang GL, Petrovsky N, Kwoh CK et al (2006) PRED(TAP): a system for prediction of peptide binding to the human transporter associated with antigen processing. Immunome Res 2:3
Petrovsky N, Brusic V (2004) Virtual models of the HLA class I antigen processing pathway. Methods 34:429–435
Gomez-Perosanz M, Ras-Carmona A, Reche PA (2020) PCPS: a web server to predict proteasomal cleavage sites. Methods Mol Biol 2131:399–406
Bhasin M, Raghava GP (2005) Pcleavage: an SVM based method for prediction of constitutive proteasome and immunoproteasome cleavage sites in antigenic sequences. Nucleic Acids Res 33:W202–W207
Kalita JK, Chandrashekar K, Hans R et al (2006) Computational modelling and simulation of the immune system. Int J Bioinforma Res Appl 2:63–88
Pizza M, Scarlato V, Masignani V et al (2000) Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287:1816–1820
Gallimore A, Hengartner H, Zinkernagel R (1998) Hierarchies of antigen-specific cytotoxic T-cell responses. Immunol Rev 164:29–36
Morris S, Kelley C, Howard A et al (2000) The immunogenicity of single and combination DNA vaccines against tuberculosis. Vaccine 18:2155–2163
Zhao B, Sakharkar KR, Lim CS et al (2007) MHC–peptide binding prediction for epitope based vaccine design. Int J Integr Biol 1:127–140
Florea L, Halldórsson B, Kohlbacher O et al (2003) Epitope prediction algorithms for peptide-based vaccine design. Proc IEEE Comput Soc Bioinform Conf 2:17–26
Doytchinova IA, Flower DR (2007) VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics 8:4
Harish N, Gupta R, Agarwal P et al (2006) DyNAVacS: an integrative tool for optimized DNA vaccine design. Nucleic Acids Res 34:W264–W266
Vivona S, Bernante F, Filippini F (2006) NERVE: new enhanced reverse vaccinology environment. BMC Biotechnol 6:35
He Y, Xiang Z, Mobley HL (2010) Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine development. J Biomed Biotechnol 2010:297505
He Y, Racz R, Sayers S et al (2014) Updates on the web-based VIOLIN vaccine database and analysis system. Nucleic Acids Res 42:D1124–D1132
Gong T, Cai Z (2005) Visual modeling and simulation of adaptive immune system. Conf Proc IEEE Eng Med Biol Soc 2005:6116–6119
De Groot AS, Rappuoli R (2004) Genome-derived vaccines. Expert Rev Vaccines 3:59–76
Castiglione F, Liso A (2005) The role of computational models of the immune system in designing vaccination strategies. Immunopharmacol Immunotoxicol 27:417–432
Bahrami AA, Payandeh Z, Khalili S et al (2019) Immunoinformatics: in silico approaches and computational design of a multi-epitope, immunogenic protein. Int Rev Immunol 38:307–322
Imler JL, Hoffmann JA (2001) Toll receptors in innate immunity. Trends Cell Biol 11:304–311
Enshell-Seijffers D, Denisov D, Groisman B et al (2003) The mapping and reconstitution of a conformational discontinuous B-cell epitope of HIV-1. J Mol Biol 334:87–101
Acknowledgments
This work was supported by the COVID-19 Research Projects of West China Hospital Sichuan University (Grant no. HX-2019-nCoV-057), the Regional Innovation Cooperation between Sichuan and Guangxi Provinces (2020YFQ0019) and the National Natural Science Foundation of China (32070671).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Joon, S., Singla, R.K., Shen, B. (2022). Vaccines and Immunoinformatics for Vaccine Design. In: Shen, B. (eds) Translational Informatics. Advances in Experimental Medicine and Biology, vol 1368. Springer, Singapore. https://doi.org/10.1007/978-981-16-8969-7_5
Download citation
DOI: https://doi.org/10.1007/978-981-16-8969-7_5
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-8968-0
Online ISBN: 978-981-16-8969-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)